AdvertisementCancer Society Asks Regulators To Limit Insurers' Charges For Key DrugsNovember 19, 2015Julie ApplebyfacebookEmailBreast cancer drug Herceptin is one of the medicines that are typically covered by insurers but often at a high out-of-pocket cost for patients. (Getty Images)
